Evidence map›Paper›PMID 25337139›Full record

ReviewJournal of contemporary brachytherapy2014

Brachytherapy in India - a long road ahead.

Susovan Banerjee, Umesh Mahantshetty, Shyamkishore Shrivastava

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of contemporary brachytherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07290972 (Compliance to Cervical Cancer Chemoradiation Guidelines), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07290972 recruitingnot on this mapstarted 2021, after this paper: background citation

Compliance to Cervical Cancer Chemoradiation Guidelines: A Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

Typeobservational_patient_registrySponsorTata Memorial HospitalRan2021 to 2026Enrolled618ConditionsCervical Cancer Screening, Gynecologic Cancers, Treatment Compliance, ChemoradiotherapyArmsNot applicable- observational study
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Gynaecological Oncology in India: Past, Present and Future.Indian journal of surgical oncology · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Susovan BanerjeeDepartment of Radiation Oncology, Vienna General Hospital, Vienna, Austria.
Umesh MahantshettyDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
Shyamkishore ShrivastavaDepartment of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brachytherapy can play a very important role in the definitive cure by radiation therapy in India. However, except for in a handful of centres, the majority of hospitals use it only for intracavitary treatment. The most probable reasons for such are the lack of logistical resources in terms of trained personal and supporting staff, rather than lack of radiotherapy machines and equipment. In this article, the authors look into the various aspects of brachytherapy in India: from its beginning to present days. The authors point out the resources available, shortcomings, and some possible solutions to make use of brachytherapy more popular and effective. Apart from presenting a picture of the present scenario, the article pays attention to the positive signs of brachytherapy becoming more popular in the near future.

Indexed as

brachytherapychallenges and promisesIndia

Identifiers

PMID25337139
PMCPMC4200190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.